Clin Cancer Res 13(9):26582666 Hiramatsu K, Asaba Y, Takeshita S, Nimura Y, Tatsumi S, Katagiri N, Niida S, Nakajima T, Tanaka S, Ito M, Karsenty G, Ikeda K (2007) Overexpression of gamma-glutamyltransferase in transgenic mice accelerates bone resorption and causes osteoporosis
Because GLP-1 medications slow gastric motility, they can worsen bacterial overgrowth, leading to more fermentation and significantly more gas production
May even help ACL ligaments heal
In the connection between mitochondrial metabolism and aging, prior work reported decreased levels of LAC in subjects with Alzheimers disease (AD) as compared to cognitively healthy controls, with intermediate levels in subjects with subjective memory complaint or mild cognitive impairment [64]
Currently, there is no Ozempic class action lawsuit in progress, nor is there a class action lawsuit for other GLP-1 receptor agonists (RAs)
Clinical studies and translational investigations have reported changes in body weight, adiposity measures, and related metabolic markers, supporting the use of retatrutide as a research tool for examining multi-receptor regulation of adipose tissue biology and systemic metabolic signaling [2][3][5]
